Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 4217
  • 4218
  • 4219
  • …
  • ›
  • »

2026-02-25

Saga Pure: Fourth quarter 2025 financial results

2026-02-25

Atrium Ljungberg 2025 Annual Report and Sustainability Report

2026-02-25

EQS-News: BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds

2026-02-25

EQS-News: EVN AG: Business development in the first quarter of 2025/26

2026-02-25

Pulse Seismic Inc. declares CAD 0.0175 dividend

2026-02-25

OPmobility reports margin growth in 2025, confirms Burelle as CEO

2026-02-25

Adecco Group Inc. Profit Rises In Q4

2026-02-25

Meren Energy Inc. declares CAD 0.0371 dividend

2026-02-25

NORBIT – Advanced negotiations regarding a NOK 115 million contract

2026-02-25

Basilea receives further USD 6 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam

2026-02-25

Critica drills into Jupiter as rare earths upgrade heats up

2026-02-25

Cytokinetics aims for over 50% new patient share for MYQORZO by end of 2026 as global commercial launch accelerates

  • «
  • ‹
  • …
  • 4217
  • 4218
  • 4219
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 27/Apr/2026 11:23:27
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies